Preliminary reports reveal conolidine may perhaps inhibit precise ion channels, lowering neuronal excitability and limiting soreness alerts. This mechanism is especially appropriate in neuropathic agony, where abnormal signaling causes persistent pain. Moreover, conolidine appears to affect G protein-coupled receptor (GPCR) pathways integral to dis